Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sae Jeong Ahn"'
Autor:
Jason Ho, Chelsie Macedo, Garrett Cyprus, Rajay Pandit, Anya Polovina, Nadja Kern, Abrahim Hussain, Sae Jeong Ahn, William Crago, Emily Rowell, Florian J Sulzmaier, John C Timmer, Brendan P Eckelman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background As a major driver of lymphocyte proliferation and activation interleukin 2 (IL-2) is a crucial mediator for antitumor responses. Despite promising activity in a subset of patients, wider therapeutic utility of IL-2 (aldesleukin) has been h
Externí odkaz:
https://doaj.org/article/1128664e4a4f45238e95ab92d708e9bf
Autor:
Heather Kinkead, Chelsie Macedo, Angelica Sanabria, Rajay Pandit, Florian Sulzmaier, John Timmer, Brendan Eckelman, Analeah Heidt, Anya Polovina, Nadja Kern, Abrahim Hussain, Sae Jeong Ahn, William Crago
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c3600c19b90545af82b567ddd7c57bd7
Autor:
Bryan Becklund, Kaitlyn Robinson, Kyle Jones, Angelica Sanabria, Elisebeth Torretti, Andrew Eckles, Abrahim Hussain, Sae Jeong Ahn, Rajay Pandit, Florian Sulzmaier, John Timmer, Brendan Eckelman
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Florian J Sulzmaier, Nadja Kern, Sae Jeong Ahn, Anya Polovina, Jason Ho, Abrahim Hussain, Garrett Cyprus, Chelsie Macedo, Rajay Pandit, William Crago, Emily Rowell, John C Timmer, Brendan P Eckelman
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006116
BackgroundAs a major driver of lymphocyte proliferation and activation interleukin 2 (IL-2) is a crucial mediator for antitumor responses. Despite promising activity in a subset of patients, wider therapeutic utility of IL-2 (aldesleukin) has been ha
Autor:
Angelica Sanabria, Heather Kinkead, Rajay Pandit, Florian Sulzmaier, Chelsie Macedo, Sae Jeong Ahn, Brendan P. Eckelman, Crago William, Anya Polovina, Nadja Kern, Timmer John C, Abrahim Hussain, Analeah Heidt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundNatural Killer (NK) cells play a pivotal role in cancer immunosurveillance due to their potent cytolytic activity and NK cell-centric therapies have emerged as safer alternatives to targeting T cells.1 2 Interleukin 2 (IL-2) drives NK cell
Autor:
Katelyn M. Willis, Margaret Haerr, Marchelle Meza, Sae Jeong Ahn, Michael Kaplan, Georgina Ortiz-Barquero, Rajay Pandit, Rafael Abalos, Yao Chen, Samuel Holley, Raul Lozano, Iljin Hwang, Emily Rowell, Brendan P. Eckelman
Publikováno v:
Cancer Research. 82:2912-2912
Bispecific T cell engagers that target CD3 on T cells and cell-surface antigens on tumor cells have demonstrated meaningful clinical activity against hematological cancers but have yet to achieve similar efficacy for the treatment of solid tumors. A
Autor:
Sedtavut Nilaad, John H. Hwang, A. Moshensky, Laura E. Crotty Alexander, Sae Jeong Ahn, Elisa McEachern, Min Kwang Byun, Jason Chien, Jorge A. Masso-Silva
Publikováno v:
Infect Immun
It is widely known that cigarette smoke damages host defenses and increases susceptibility to bacterial infections. Pseudomonas aeruginosa, a Gram-negative bacterium that commonly colonizes the airways of smokers and patients with chronic lung diseas